Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
about
Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signallingPharmacotherapy and airway remodelling in asthma?Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthmaThe puzzle of immune phenotypes of childhood asthmaThe mucosal immune system in the oral cavity-an orchestra of T cell diversityTreatment of allergic asthma: modulation of Th2 cells and their responsesThe development and in vivo function of T helper 9 cellsDistinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9ICOS co-stimulatory receptor is essential for T-cell activation and functionMucin biosynthesis: upregulation of core 2 beta 1,6 N-acetylglucosaminyltransferase by retinoic acid and Th2 cytokines in a human airway epithelial cell lineGenetically manipulated mouse models of lung disease: potential and pitfallsIL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cellsNoninvasive real-time measurement of nasal mucociliary clearance in mice by pinhole gamma scintigraphy.Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells.Regulation of IL-9 expression by IL-25 signaling.Cytokines in asthma.The use of knockouts to study determinants of airway hyperresponsiveness.Airway remodeling in asthmaSafety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma.Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.Airway remodeling in asthma. Unanswered questions.Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells.Importance of cytokines in murine allergic airway disease and human asthma.Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9.Role of Tyk-2 in Th9 and Th17 cells in allergic asthma.Gene knockout models of asthma.Nitric oxide enhances Th9 cell differentiation and airway inflammation.Expression of IL-4 receptor alpha on smooth muscle cells is not necessary for development of experimental allergic asthma.Biotherapeutic targets for the treatment of allergic airway disease.Immune mechanisms in interstitial lung diseases.Type 1/Type 2 immunity in infectious diseases.TGF-beta induces IL-9 production from human Th17 cells.A brief history of IL-9IL-9 and lung fibrosis: a Th2 good guy?Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse.New insights into the role of cytokines in asthmaRemodeling of the airway epithelium in asthma.IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.
P2860
Q24532238-9B7E3355-E3E4-41C7-AE32-4C38D07378BCQ24678822-163478FC-6913-4B0A-99E3-84300D5F0F98Q24791881-B7768C71-8A34-4EC6-8ACF-9439017B46D1Q26741068-EC10AAFF-D80D-416F-89EF-C5C13D10A35FQ26851091-57034883-F93C-4A48-91A0-07D281CCC67CQ27011823-4CBD733B-1590-49A5-A703-035FF88C9E92Q28083375-220A7F77-0856-49B8-B23C-323A69453D54Q28143141-B1FC88F1-CD49-4069-84EC-865E452ADB7CQ28187985-E223DE77-C80B-46BD-82AE-7FFCD5213F93Q28297724-B2700C93-CE3F-4259-8CB0-649866F17C45Q28388821-1420CFCF-8DD2-473F-99AA-525B082C784BQ28590243-021B6AB2-5D6C-40C6-AC32-C88F0B18BDE8Q30494863-B6BD5DDD-245C-405C-9C41-CD54E98021EBQ33302897-E4F83B6C-B970-471F-B0ED-C864CEE15A44Q33532650-4E4494B5-ECB3-42D6-9913-D09AA25D9A5AQ33682703-DA9AC7AD-8681-47BD-BBA3-72A78923F168Q33717312-00C3C9D0-FE14-4046-9CE7-59E8AD28E660Q33743160-1A21795F-48B6-48DB-8421-C8BDE5633C3EQ33753444-309A876C-7A75-408F-B976-18D07A25DC18Q33831073-8ED2698A-DFAE-4419-9D85-48AFE376149DQ33835115-1BD7F9B2-35D3-4809-A623-A6996DAE2CFFQ33855162-642753F4-D8F2-4475-BA4F-9D9E41E2D501Q33860254-0164551B-C45E-4055-89AB-839C9160506DQ33902052-37394806-F4EB-4DFF-B3C5-99D76F3EE5ADQ34003580-CAC0BDE1-FA9F-4EAA-AB23-2F6A1D6573CEQ34021220-ADF0A082-1E11-4267-A515-F742BDDDC34EQ34023371-8A2D133D-EEAE-4DBE-8F84-7CEC27DC2A57Q34033726-6D2EDACE-EA61-4F8A-93EB-43AFCADD5243Q34037524-2BE9472C-9CEB-4342-9407-FFE925AC985CQ34050010-2A2A234B-D69C-4B48-99A4-62E2F1EC44DCQ34058685-C7824692-9F16-4A55-BD0C-6215D70327CCQ34105088-9FE3B084-3647-442E-9461-6F8A1A48175DQ34105379-C7926E5A-CCB5-495C-BFC0-6409079EAC93Q34113303-A14144A6-CDEB-488D-8B95-962247D822E9Q34168144-27CD78D0-7F72-4D43-A17A-AA0161C16D4CQ34221323-12813F92-71ED-46AA-A202-89C3C0B4CBD1Q34243622-A37BAE13-7401-40C5-82DE-9047D7763328Q34321721-D7CA0F27-5FDC-44DE-9F8F-919BADE96543Q34457559-19BBB369-E579-4388-8684-CCB74AD39BCFQ34589849-A1868C9E-FA39-49B5-BE67-0D9975002249
P2860
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@ast
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@en
type
label
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@ast
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@en
prefLabel
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@ast
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@en
P2093
P2860
P921
P356
P1476
Expression of interleukin 9 in ...... bronchial hyperresponsiveness
@en
P2093
J A Rankin
R A Flavell
U A Temann
P2860
P304
P356
10.1084/JEM.188.7.1307
P407
P577
1998-10-01T00:00:00Z